Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Henry-Vincent Charbonné"'
Autor:
Marie Maynadier, Benedikt Schoser, Marcel Garcia, Morgane Daurat, Anastasia Godefroy, Afitz Da Silva, Magali Gary-Bobo, Ilaria Basile, Khaled El Cheikh, Catherine Caillaud, Sabrina Sacconi, Henry-Vincent Charbonné, Alain Morère
Publikováno v:
Journal of Cellular and Molecular Medicine
Journal of Cellular and Molecular Medicine, Wiley Open Access, 2019, 23 (9), pp.6499-6503. ⟨10.1111/jcmm.14516⟩
Journal of Cellular and Molecular Medicine, Wiley Open Access, 2019, 23 (9), pp.6499-6503. ⟨10.1111/jcmm.14516⟩
In the search of a better enzyme therapy in Pompe disease, the conjugation of mannose 6‐phosphonates to the recombinant enzyme appeared as an enhancer of its efficacy. Here, we demonstrated that the increased efficacy of the conjugated enzyme is pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8069f72ba45b72e7cc0ea0e2f32c4393
https://hal.archives-ouvertes.fr/hal-03116444
https://hal.archives-ouvertes.fr/hal-03116444
Autor:
Marcel Garcia, Morgane Daurat, Alain Morère, Marc Perez, Alice Harmois, Marie Maynadier, Afitz Da Silva, Khaled El Cheikh, Catherine Caillaud, Ilaria Basile, Bernard Pau, Magali Gary-Bobo, Henry-Vincent Charbonné, Anastasia Godefroy
Publikováno v:
Journal of Controlled Release
Journal of Controlled Release, Elsevier, 2018, 269, pp.15-23. ⟨10.1016/j.jconrel.2017.10.043⟩
Journal of Controlled Release, Elsevier, 2018, 269, pp.15-23. ⟨10.1016/j.jconrel.2017.10.043⟩
Pompe disease is a rare disorder due to deficiency of the acid a-glucosidase (GAA) treated by enzyme replacement therapy. The present authorized treatment with rhGAA, the recombinant human enzyme, provides an important benefit in the infantile onset;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dcbca864b4ea11ed8d8c1f95a3c6400
https://hal.archives-ouvertes.fr/hal-01837837
https://hal.archives-ouvertes.fr/hal-01837837
Autor:
Henry-Vincent Charbonné
Publikováno v:
Obésité. 1:5-5